"I-Fatty Liver Risk - Ukuhlolisiswa Kwezempilo Yesibindi" iyithuluzi lezokwelapha lokuqagela ukuthi unesibindi esinamafutha emiphumeleni yokuhlolwa komtholampilo kanye nasemiphumeleni yaselebhu. Kudinga umsebenzisi ukufaka inkomba yomzimba womzimba (BMI), isinqe sesinqe, i-gamma-glutamyl transferase (GGT), kanye nama-triglicerydes. Uhlelo lokusebenza lwe- "Fatty Liver Risk - Screening of Liver Health" luzobe selubeka ubungozi ezigabeni ezi-3 (eziphansi, eziphakathi nendawo kanye nobungozi obukhulu). Le "Fatty Liver Risk - Screening of Liver Health" ihloselwe ukusiza udokotela ukubala ubungozi bomuntu otholwe enesibindi esinamafutha ngokubala inkomba yesibindi enamafutha.
Kunezici eziningana ze- "Fatty Liver Risk - Screening of Liver Health", okungukuthi:
🔸 Ilula futhi kulula kakhulu ukuyisebenzisa.
Ukubalwa okuqondile kwenkomba yesibindi enamafutha.
Erm Thola ubungozi bokuthola isifo sesibindi esinamafutha.
🔸 Kumahhala ngokuphelele. Landa manje!
Engcupheni ephansi (okunamafutha okukhomba isibindi <30), isibindi esinamafutha singakhishwa ngaphandle. Futhi kubantu abasengozini enkulu (fatty index index> 60), isibindi esinamafutha singalawulwa. Kubantu abanomphumela ophakathi noma onobungozi obukhulu, cabanga ngokuhlolwa kwe-ultrasound ukuze kuqinisekiswe isifo esinamafutha sesibindi. Lolu hlelo lokusebenza lwe- "Fatty Liver Risk - Screening of Liver Health" lungasetshenziswa yinoma ngubani onobungozi besibindi esinamafutha, njengokukhuluphala noma ukukhuluphala ngokweqile, ukuba nohlobo 2 lwesifo sikashukela noma ukumelana ne-insulin, nokuba nama-syndromes we-metabolic. Ukuxilongwa kwesibindi okunamafutha kwangaphambilini kungaholela ekwelashweni kwangaphambili kanye nomphumela ongcono. Siyethemba ukuthi lolu hlelo lokusebenza lwe- "Fatty Liver Risk - Screening of Liver Health" lungasetshenziswa kabanzi.
Kubuyekezwe ngo-
Jun 29, 2021